Technology transfer

Collaborations with companies

July 2012 - July 2015.- Collaboration project for the study of new therapeutic approaches based on essential fatty acid derivates led to unmet oncological and neurological diseases. Co-financed by INNPACTO 2012 subprogram of Ministerio de Economia y Competitividad.

July 2011 - July 2013.- Collaboration project for the study of new therapeutic approaches for amyotrophic lateral sclerosis (STOP-ELA). Co-financed by INNPACTO 2011 subprogram of Ministerio de Ciencia e Innovación.

July 2010 - July 2012.- Collaboration project for the study of new therapeutic approaches for multiple sclerosis and amyotrophic lateral sclerosis. Co-financed by INNPACTO 2010 subprogram of Ministerio de Ciencia e Innovación.

January 2009 - may 2010.- Collaboration project with company Bioteic Giny AIE for studying the effect of KCOs in inflamatory brain activity.

Patents

Genetic variant in the CX3CR1 gene as a prognosis marker for amyotrophyc lateral sclerosis (ALS). (2013) application PCT/EP2013/382200.

Diazoxide for use in the treatment a central nervous system (CNS) autoinmune demyelinating disease. (2010) application EP10150027.

Immunotherapy compositions for the treatment and prevention of amyloidosis. (2008) application PCT/EP2009/059772

"Compuestos para el tratamiento de la inflamación del sistema nervioso central". (2004) application P200401627

"Compuestos para el tratamiento del daño agudo del sistema nervioso central". (2004) application P200401628